Diagnostic Imaging Services Market (By Modality: X-ray, Nuclear Medicine Scans, MRI Scans, CT scans, Ultrasounds; By End Use: Hospitals and Diagnostic Imaging Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2021 – 2030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Diagnostic Imaging Services Market 

5.1. COVID-19 Landscape: Diagnostic Imaging Services Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Diagnostic Imaging Services Market, By Modality

8.1. Diagnostic Imaging Services Market, by Modality Type, 2021-2030

8.1.1. X-ray

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Nuclear Medicine Scans

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. MRI Scans

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. CT Scans

8.1.4.1. Market Revenue and Forecast (2019-2030)

8.1.5. Ultrasound

8.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Diagnostic Imaging Services Market, By End Use

9.1. Diagnostic Imaging Services Market, by End Use, 2021-2030

9.1.1. Hospitals

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Diagnostic Imaging Centers

9.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Diagnostic Imaging Services Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Modality (2019-2030)

10.1.2. Market Revenue and Forecast, by End Use (2019-2030)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Modality (2019-2030)

10.1.3.2. Market Revenue and Forecast, by End Use (2019-2030)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Modality (2019-2030)

10.1.4.2. Market Revenue and Forecast, by End Use (2019-2030)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Modality (2019-2030)

10.2.2. Market Revenue and Forecast, by End Use (2019-2030)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Modality (2019-2030)

10.2.3.2. Market Revenue and Forecast, by End Use (2019-2030)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Modality (2019-2030)

10.2.4.2. Market Revenue and Forecast, by End Use (2019-2030)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Modality (2019-2030)

10.2.5.2. Market Revenue and Forecast, by End Use (2019-2030)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Modality (2019-2030)

10.2.6.2. Market Revenue and Forecast, by End Use (2019-2030)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Modality (2019-2030)

10.3.2. Market Revenue and Forecast, by End Use (2019-2030)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Modality (2019-2030)

10.3.3.2. Market Revenue and Forecast, by End Use (2019-2030)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Modality (2019-2030)

10.3.4.2. Market Revenue and Forecast, by End Use (2019-2030)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Modality (2019-2030)

10.3.5.2. Market Revenue and Forecast, by End Use (2019-2030)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Modality (2019-2030)

10.3.6.2. Market Revenue and Forecast, by End Use (2019-2030)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Modality (2019-2030)

10.4.2. Market Revenue and Forecast, by End Use (2019-2030)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Modality (2019-2030)

10.4.3.2. Market Revenue and Forecast, by End Use (2019-2030)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Modality (2019-2030)

10.4.4.2. Market Revenue and Forecast, by End Use (2019-2030)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Modality (2019-2030)

10.4.5.2. Market Revenue and Forecast, by End Use (2019-2030)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Modality (2019-2030)

10.4.6.2. Market Revenue and Forecast, by End Use (2019-2030)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Modality (2019-2030)

10.5.2. Market Revenue and Forecast, by End Use (2019-2030)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Modality (2019-2030)

10.5.3.2. Market Revenue and Forecast, by End Use (2019-2030)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Modality (2019-2030)

10.5.4.2. Market Revenue and Forecast, by End Use (2019-2030)

Chapter 11. Company Profiles

11.1. Global Diagnostics

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. RadNet, Inc

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Alliance Medical

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Center for Diagnostic Imaging, Inc

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Medica Group

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Novant Health

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Concord Medical Services Holdings Limited

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. InHealth Group

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Sonic Healthcare

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Healthcare Imaging Services Pty Ltd.

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

PROCEED TO BUY

   USD 4900.00
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample